Best Stocks to Buy in May 2024: TSX Healthcare Sector

Three outperforming stocks with strong fundamentals are the best buys in the healthcare sector in May 2024.

| More on:
Doctor talking to a patient in the corridor of a hospital.

Source: Getty Images

The Canadian and US stock markets have the same mix of industry sectors but differ in equity weights by sector. One glaring difference is healthcare. In the US S&P 500 Index, it is the third-largest sector (12.6%) after information technology (28.9%) and financials (13%).

In the S&P/TSX Composite Index, healthcare (0.3%) is the smallest among the 11 primary sectors, while financials (31.3%) and energy (17.1%) are the heavyweights. The healthcare sector seldom outperforms, although, in 2024, individual components beat the broader market.

This May, best in the lot are Vitalhub (TSX:VHI) and Medical Facilities Corp. (TSX:DR). If you’re after monthly passive income and don’t expect much on price appreciation, high-yield NorthWest Healthcare Properties (TSX:NWH.UN) is the logical choice.

Digital transformation                

Vitalhub is obscure, but the healthcare stock is flying high. At $6.63 per share, current investors enjoy a 62.5% year-to-date gain. The trailing one-year price return is 142.9%. Had you invested $6,500 a year ago, your money would be worth $15,785.71 today.

The $336 million company provides software dedicated to health and human services providers. Its primary purpose is to improve care delivery by developing an ecosystem of harmonious solutions for these sectors. Given the Q1 2024 financial results, its CEO, Dan Matlow, said VitalHub is well-positioned to continue its growth trajectory.

In the three months ended March 31, 2024, revenue and annual recurring revenue (ARR) increased 21% to $15.3 million and $47.8 million, respectively. Notably, EBITDA rose 56% to $3.1 million, while net income soared 713% year over year to $1.3 million.   

“Our strong financial position supports our ambitious growth plans and our commitment to leading the digital transformation in healthcare,” added Matlow.

Unique business model

Prospective investors can earn two ways from Medical Facilities: capital gains and dividends. At $11.80 per share, the healthcare stock is up 32.4% year to date and pays a decent 2.83% dividend. This $288.8 million market cap company owns or has controlling interests in specialty surgical hospitals in Arkansas, Oklahoma, and South Dakota, as well as an ambulatory surgery centre in California.

The business model is unique in that physicians have direct involvement in operations through established partnerships. Medical Facilities’ competitive advantages are their high-quality surgical facilities, the ever-increasing demand for health care, and the growing but fragmented outpatient services market.

In Q1 2024, facility service revenue and income from operations rose 4.5% and 29.6% year over year respectively to $108.3 million and $17.5 million. Because of the strong cash flows, the company reduced debt by $5 million, and the Board approved an 11.8% dividend hike.

Only REIT in the cure sector

NorthWest Healthcare trades at $5.33 per share (+6% year-to-date) and pays a hefty 7.05% dividend. A $7,000 investment today would transform into a recurring monthly passive income of $41.12. The investment pitch for this healthcare-related real estate stock is simple.

This $1.3 billion real estate investment trust (REIT) is the only REIT in the cure sector. NorthWest Healthcare owns and operates healthcare real estate infrastructure. The medical office buildings, hospitals, and clinics are in North America, Brazil, Europe, and Australasia. Besides stable occupancies, the leases are long-term.

Strong fundamentals

Vitalhub, Medical Facilities, and NorthWest Healthcare Properties boast strong fundamentals. The choice depends on your investment objectives: capital gains, dividend income, or both.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Vitalhub. The Motley Fool recommends NorthWest Healthcare Properties Real Estate Investment Trust. The Motley Fool has a disclosure policy.

More on Dividend Stocks

Person holding a smartphone with a stock chart on screen
Dividend Stocks

Beyond Telus: A High-Yield Stock Perfect for Income Lovers

Brookfield Renewable Partners (TSX:BEP.UN) is a standout income stock fit for long-term investors.

Read more »

dividend growth for passive income
Dividend Stocks

5 TSX Dividend Champions Every Retiree Should Consider

These top TSX companies have increased their dividends annually for decades.

Read more »

A worker gives a business presentation.
Dividend Stocks

The Bank of Canada Just Spoke: Here’s What I’d Buy in a TFSA Now

With the Bank of Canada on pause, TFSA investors can shift from rate-watching to owning businesses that compound through ordinary…

Read more »

Concept of multiple streams of income
Dividend Stocks

4 Dividend Stocks to Double Up on Right Now

These dividend stocks will likely maintain their dividend growth streak, making them reliable investments to double up on right now.

Read more »

Electricity transmission towers with orange glowing wires against night sky
Dividend Stocks

Outlook for Northland Power Stock in 2026

Northland’s Taiwan offshore wind ramp is the make-or-break story for 2026, and delays are already reshaping cash flow expectations.

Read more »

Pile of Canadian dollar bills in various denominations
Dividend Stocks

My 3 Favourite Stocks for Monthly Passive Income

Supported by strong cash flows, attractive yields, and visible growth prospects, these three monthly-paying dividend stocks can meaningfully enhance your…

Read more »

Piggy bank with word TFSA for tax-free savings accounts.
Dividend Stocks

The Best Canadian Stocks to Buy and Hold Forever in a TFSA

Discover the best Canadian stocks to buy and hold forever in a TFSA, including top dividend payers and defensive compounders…

Read more »

man looks worried about something on his phone
Dividend Stocks

Rogers Stock: Buy, Sell, or Hold in 2026?

Rogers looks like a classic “boring winner” but price wars, debt, and heavy network spending can still bite.

Read more »